Comirnaty PI - Private | Pfizer PI index

This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for COMIRNATY^® KP.2▼ (mRNA encoding KP.2) (pre-filled syringe) and COMIRNATY^® JN.1▼ (bretovameran) COVID-19 mRNA Vaccine (pre-filled syringe) for use in the private market

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

COMIRNATY JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe

COMIRNATY KP.2 30 microgram/dose dispersion for injection in pre-filled syringe

PP-CMR-GBR-0796. March 2025

Prescribing Information (PI) for COMIRNATY® KP.2▼ (mRNA encoding KP.2) (pre-filled syringe) and COMIRNATY® JN.1▼ (bretovameran) COVID-19 mRNA Vaccine (pre-filled syringe) for use in the private market

United Kingdom

COMIRNATY JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe

COMIRNATY KP.2 30 microgram/dose dispersion for injection in pre-filled syringe

Prescribing Information (PI) for COMIRNATY^® KP.2▼ (mRNA encoding KP.2) (pre-filled syringe) and COMIRNATY^® JN.1▼ (bretovameran) COVID-19 mRNA Vaccine (pre-filled syringe) for use in the private market